This issue marks the twenty-fifth year of our Society's publication. In recognition of this milestone, we will invite a review of this past quarter century to describe the impact of applications of toxicologic pathology in the improvement of the well-being of all species. As promised, we have worked to redesign our journal. Our editorial team has surpassed my expectations, but we must redouble our efforts as the challenges to achieve and maintain world leadership in toxicology and pathology communications are daunting. This first year, we have taken a global view and seemingly significant steps as agents of change.
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We have attempted to broaden the impact by establishing four component sub-disciplines while sharpening our focus reflective of the depth and breadth of toxicologic pathology. The component Section Editors enable and ensure the enhancement of depth, even with the expanded scope. We have worked to increase the reader friendliness of Toxicologic Pathology.
In 1996, species from fish to rats to humans were reported in articles reflecting the critical importance of trans-species assessment. Evaluations through application of state-of-the-art technology from in situ hybridization to confocal microscopy in search for the effects of chemicals, foods, and other environmental agents or drugs illustrate the diversity of techniques prerequisite to refined risk assessment. Articles involving standard-setting in the practice of toxicologic pathology as well as research reports addressing mechanisms of carcinogenesis mirror the multiplicity of skill sets necessary to reliably assess the effects of novel xenobiotics in the environment.
Following a year of redesign, we will focus for 1997 on the continuous effort to enhance the impact of this leading toxicologic pathology communication vehicle.
Two additional initiatives are launched as follows.
INFORMATION TECHNOLOGY
The relationship between humans and computers is changing rapidly. No health scientist today can compete without computer assistance. Our journal, as the spokespiece for the Society of Toxicologic Pathologists, must also respond to maintain its leadership position in communications in toxicologic pathology. Dr. Charlotte Keenan and the Internet Committee have put our journal on the World Wide Web, including titles and abstracts. We are actively exploring and intend to make the entire contents available electronically, but have not yet defined the process. We would like to consider much of our &dquo;Current Issues&dquo; section as a candidate for a more dynamic and interactive vehicle than is possible through the current publication. The opportunity for current discussion critical to the practice of toxicologic pathology on our website via an STP member bulletin board will be addressed by this same committee.
INTEGRITY AND TOXICOLOGIC PATHOLOGY
We have an excellent editorial staff and a rigorous process for manuscript approval. We also try to publish papers that are provocative and maybe even controversial.
At the same time, the United States Commission on Research Integrity issued a report in 1995 exhorting professional societies to develop and disseminate ethical standards for their discipline.
Our society must encourage constructive discussion to ensure high standards in integrity without constraining creativity in formulating and testing hypotheses. Dr. Bernie Wagner has initiated activity to begin these discussions and to create a written code of conduct for our journal this year. Our journal will contribute to the solid culture of first-rate research through processes designed to avoid publishing compromised data. CARL L. ALDEN, D.V.M.
Editor, Toxicologic Pathology

